Zinc transporters and their role in the pancreatic β-cell

Journal of Diabetes Investigation

Volumn 3, Issue 3, 2012, Pages 202-211

  Lemaire, Katleen ^a   Chimienti, Fabrice ^b   Schuit, Frans ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b CEA GRENOBLE   (France)

Author keywords

Insulin crystallization; Pancreatic cell; Zinc transporter 8

Indexed keywords

4 AMINOBUTYRIC ACID; BETA ACTIN; CARBOXYPEPTIDASE H; EPITOPE; FURIN; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8;

3' UNTRANSLATED REGION; CRYSTALLIZATION; DOWN REGULATION; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LANGERHANS CELL; MUTAGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SECRETORY GRANULE; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; ZINC HOMEOSTASIS; ZNT8 GENE;

EID: 84861991846     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/j.2040-1124.2012.00199.x     Document Type: Review

References (93)

1. Truong-Tran AQ, Grosser D, Ruffin RE, et al. Apoptosis in the normal and inflamed airway epithelium: role of zinc in epithelial protection and procaspase-3 regulation. Biochem Pharmacol 2003; 66: 1459-1468.
2. Frederickson CJ, Koh JY, Bush AI. The neurobiology of zinc in health and disease. Nat Rev Neurosci 2005; 6: 449-462.
3. Hurley LS, Shrader RE. Abnormal development of preimplantation rat eggs after three days of maternal dietary zinc deficiency. Nature 1975; 254: 427-429.
4. Zalewski PD, Millard SH, Forbes IJ, et al. Video image analysis of labile zinc in viable pancreatic islet cells using a specific fluorescent probe for zinc. J Histochem Cytochem 1994; 42: 877-884.
5. Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 2006; 20: 3-18.
6. Tomat AL, Costa Mde L, Arranz CT. Zinc restriction during different periods of life: influence in renal and cardiovascular diseases. Nutrition 2011; 27: 392-398.
7. Wuehler SE, Peerson JM, Brown KH. Use of national food balance data to estimate the adequacy of zinc in national food supplies: methodology and regional estimates. Public Health Nutr 2005; 8: 812-819.
8. Black RE, Allen LH, Bhutta ZA, et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 2008; 371: 243-260.
9. Foster M, Samman S. Zinc and redox signaling: perturbations associated with cardiovascular disease and diabetes mellitus. Antioxid Redox Signal 2010; 13: 1549-1573.
10. Jansen J, Karges W, Rink L. Zinc and diabetes - clinical links and molecular mechanisms. J Nutr Biochem 2009; 20: 399-417.
11. McNair P, Kiilerich S, Christiansen C, et al. Hyperzincuria in insulin treated diabetes mellitus - its relation to glucose homeostasis and insulin administration. Clin Chim Acta 1981; 112: 343-348.
12. Cunningham JJ, Fu A, Mearkle PL, et al. Hyperzincuria in individuals with insulin-dependent diabetes mellitus: concurrent zinc status and the effect of high-dose zinc supplementation. Metabolism 1994; 43: 1558-1562.
13. Chen MD, Song YM, Lin PY. Zinc effects on hyperglycemia and hypoleptinemia in streptozotocin-induced diabetic mice. Horm Metab Res 2000; 32: 107-109.
14. Anderson RA, Roussel AM, Zouari N, et al. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr 2001; 20: 212-218.
15. Simon SF, Taylor CG. Dietary zinc supplementation attenuates hyperglycemia in db/db mice. Exp Biol Med (Maywood) 2001; 226: 43-51.
16. Lichten LA, Cousins RJ. Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr 2009; 29: 153-176.
17. Ohno S. Gene duplication and the uniqueness of vertebrate genomes circa 1970-1999. Semin Cell Dev Biol 1999; 10: 517-522.
18. Eide DJ. The SLC39 family of metal ion transporters. Pflugers Arch 2004; 447: 796-800.
19. Sekler I, Sensi SL, Hershfinkel M, et al. Mechanism and regulation of cellular zinc transport. Mol Med 2007; 13: 337-343.
20. Sutherland DE, Stillman MJ. The "magic numbers" of metallothionein. Metallomics 2011; 3: 444-463.
21. Chimienti F, Devergnas S, Favier A, et al. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 2004; 53: 2330-2337.
22. Chimienti F, Devergnas S, Pattou F, et al. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci 2006; 119: 4199-4206.
23. Wijesekara N, Dai FF, Hardy AB, et al. Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Diabetologia 2010; 53: 1656-1668.
24. Murgia C, Devirgiliis C, Mancini E, et al. Diabetes-linked zinc transporter ZnT8 is a homodimeric protein expressed by distinct rodent endocrine cell types in the pancreas and other glands. Nutr Metab Cardiovasc Dis 2009; 19: 431-439.
25. Tamaki M, Fujitani Y, Uchida T, et al. Downregulation of ZnT8 expression in pancreatic beta-cells of diabetic mice. Islets 2009; 1: 124-128.
26. Lemaire K, Ravier MA, Schraenen A, et al. Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice. Proc Natl Acad Sci USA 2009; 106: 14872-14877.
27. Nicolson TJ, Bellomo EA, Wijesekara N, et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 2009; 58: 2070-2083.
28. Lu M, Fu D. Structure of the zinc transporter YiiP. Science 2007; 317: 1746-1748.
29. Kambe T, Narita H, Yamaguchi-Iwai Y, et al. Cloning and characterization of a novel mammalian zinc transporter, zinc transporter 5, abundantly expressed in pancreatic beta cells. J Biol Chem 2002; 277: 19049-19055.
30. Huang L, Yan M, Kirschke CP. Over-expression of ZnT7 increases insulin synthesis and secretion in pancreatic beta-cells by promoting insulin gene transcription. Exp Cell Res 2010; 316: 2630-2643.
31. Fukunaka A, Suzuki T, Kurokawa Y, et al. Demonstration and characterization of the heterodimerization of ZnT5 and ZnT6 in the early secretory pathway. J Biol Chem 2009; 284: 30798-30806.
32. Adlard PA, Parncutt JM, Finkelstein DI, et al. Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimer's disease? J Neurosci 2010; 30: 1631-1636.
33. Atouf F, Czernichow P, Scharfmann R. Expression of neuronal traits in pancreatic beta cells. Implication of neuron-restrictive silencing factor/repressor element silencing transcription factor, a neuron-restrictive silencer. J Biol Chem 1997; 272: 1929-1934.
34. Thiel G, Schuit F. No REST for healthy beta cells. Diabetologia 2008; 51: 1343-1346.
35. Smidt K, Jessen N, Petersen AB, et al. SLC30A3 responds to glucose- and zinc variations in beta-cells and is critical for insulin production and in vivo glucose-metabolism during beta-cell stress. PLoS One 2009; 4: e5684.
36. Bellomo EA, Meur G, Rutter GA. Glucose Regulates Free Cytosolic Zn2+ Concentration, Slc39 (ZiP), and Metallothionein Gene Expression in Primary Pancreatic Islet {beta}-Cells. J Biol Chem 2011; 286: 25778-25789.
37. Lukowiak B, Vandewalle B, Riachy R, et al. Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe. J Histochem Cytochem 2001; 49: 519-528.
38. Kim BJ, Kim YH, Kim S, et al. Zinc as a paracrine effector in pancreatic islet cell death. Diabetes 2000; 49: 367-372.
39. Chimienti F, Seve M, Richard S, et al. Role of cellular zinc in programmed cell death: temporal relationship between zinc depletion, activation of caspases, and cleavage of Sp family transcription factors. Biochem Pharmacol 2001; 62: 51-62.
40. Schmitt S, Kury S, Giraud M, et al. An update on mutations of the SLC39A4 gene in acrodermatitis enteropathica. Hum Mutat 2009; 30: 926-933.
41. Weaver BP, Andrews GK. Regulation of zinc-responsive Slc39a5 (Zip5) translation is mediated by conserved elements in the 3'-untranslated region. Biometals 2011; doi.
42. Mihelich BL, Khramtsova EA, Arva N, et al. The miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. J Biol Chem 2011; 286: 44503-44511.
43. Egefjord L, Jensen JL, Bang-Berthelsen CH, et al. Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis? BMC Endocr Disord 2009; 9: 7.
44. El Muayed M, Billings LK, Raja MR, et al. Acute cytokine-mediated downregulation of the zinc transporter ZnT8 alters pancreatic beta-cell function. J Endocrinol 2010; 206: 159-169.
45. Pound LD, Hang Y, Sarkar SA, et al. The pancreatic islet beta-cell-enriched transcription factor Pdx-1 regulates Slc30a8 gene transcription through an intronic enhancer. Biochem J 2011; 433: 95-105.
46. Hinke SA, Hellemans K, Schuit FC. Plasticity of the beta cell insulin secretory competence: preparing the pancreatic beta cell for the next meal. J Physiol 2004; 558: 369-380.
47. Dodson G, Steiner D. The role of assembly in insulin's biosynthesis. Curr Opin Struct Biol 1998; 8: 189-194.
48. Emdin SO, Dodson GG, Cutfield JM, et al. Role of zinc in insulin biosynthesis. Some possible zinc-insulin interactions in the pancreatic B-cell. Diabetologia 1980; 19: 174-182.
49. Huang XF, Arvan P. Intracellular transport of proinsulin in pancreatic beta-cells. Structural maturation probed by disulfide accessibility. J Biol Chem 1995; 270: 20417-20423.
50. Dunn MF. Zinc-ligand interactions modulate assembly and stability of the insulin hexamer - a review. Biometals 2005; 18: 295-303.
51. Creemers JW, Jackson RS, Hutton JC. Molecular and cellular regulation of prohormone processing. Semin Cell Dev Biol 1998; 9: 3-10.
52. Paroutis P, Touret N, Grinstein S. The pH of the secretory pathway: measurement, determinants, and regulation. Physiology (Bethesda) 2004; 19: 207-215.
53. Grant PT, Coombs TL, Frank BH. Differences in the nature of the interaction of insulin and proinsulin with zinc. Biochem J 1972; 126: 433-440.
54. Kirchhoff K, Machicao F, Haupt A, et al. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 2008; 51: 597-601.
55. Scott DA. Crystalline insulin. Biochem J 1934; 28: 1592-1602.
56. Lubag AJ, De Leon-Rodriguez LM, Burgess SC, et al. Noninvasive MRI of beta-cell function using a Zn2+-responsive contrast agent. Proc Natl Acad Sci USA 2011; 108: 18400-18405.
57. Maske H. Interaction between insulin and zinc in the islets of Langerhans. Diabetes 1957; 6: 335-341.
58. Yip CC. A bovine pancreatic enzyme catalyzing the conversion of proinsulin to insulin. Proc Natl Acad Sci USA 1971; 68: 1312-1315.
59. Liu FY, Kildsig DO, Mitra AK. Insulin aggregation in aqueous media and its effect on alpha-chymotrypsin-mediated proteolytic degradation. Pharm Res 1991; 8: 925-929.
60. Smith LF. Amino acid sequences of insulins. Diabetes 1972; 21: 457-460.
61. Falkmer S, Pihl E. Structural lability of zinc-containing secretion granules of pancreatic beta-cells after exposure to hydrogen sulphide. Diabetologia 1968; 4: 239-243.
62. Smith LF. Species variation in the amino acid sequence of insulin. Am J Med 1966; 40: 662-666.
63. Zimmerman AE, Yip CC. Guinea pig insulin. I. Purification and physical properties. J Biol Chem 1974; 249: 4021-4025.
64. Havu N, Lundgren G, Falkmer S. Zinc and manganese contents of micro-dissected pancreatic islets of some rodents. A microchemical study in adult and newborn guinea pigs, rats, Chinese hamsters and spiny mice. Acta Endocrinol (Copenh) 1977; 86: 570-577.
65. Carroll RJ, Hammer RE, Chan SJ, et al. A mutant human proinsulin is secreted from islets of Langerhans in increased amounts via an unregulated pathway. Proc Natl Acad Sci USA 1988; 85: 8943-8947.
66. Gruppuso PA, Gorden P, Kahn CR, et al. Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin. N Engl J Med 1984; 311: 629-634.
67. Bristow AF. Recombinant-DNA-derived insulin analogues as potentially useful therapeutic agents. Trends Biotechnol 1993; 11: 301-305.
68. Hanna ST, Pigeau GM, Galvanovskis J, et al. Kiss-and-run exocytosis and fusion pores of secretory vesicles in human beta-cells. Pflugers Arch 2009; 457: 1343-1350.
69. Ishihara H, Maechler P, Gjinovci A, et al. Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. Nat Cell Biol 2003; 5: 330-335.
70. Ravier MA, Rutter GA. Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha-cells. Diabetes 2005; 54: 1789-1797.
71. Zhou H, Zhang T, Harmon JS, et al. Zinc, not insulin, regulates the rat alpha-cell response to hypoglycemia in vivo. Diabetes 2007; 56: 1107-1112.
72. Pipeleers DG, Schuit FC, Van Schravendijk CF, et al. Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology 1985; 117: 817-823.
73. Unger RH. Glucagon physiology and pathophysiology in the light of new advances. Diabetologia 1985; 28: 574-578.
74. Maruyama H, Hisatomi A, Orci L, et al. Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest 1984; 74: 2296-2299.
75. Wendt A, Birnir B, Buschard K, et al. Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. Diabetes 2004; 53: 1038-1045.
76. Robertson RP, Zhou H, Slucca M. A role for zinc in pancreatic islet beta-cell cross-talk with the alpha-cell during hypoglycaemia. Diabetes Obes Metab 2011; 13(Suppl 1): 106-111.
77. Hardy AB, Serino AS, Wijesekara N, et al. Regulation of glucagon secretion by zinc: lessons from the beta cell-specific Znt8 knockout mouse model. Diabetes Obes Metab 2011; 13(Suppl 1): 112-117.
78. Dettwyler W. Some aspects of zinc metabolism in diabetics. Diabetologia 1966; 2: 75-81.
79. Boesgaard TW, Zilinskaite J, Vanttinen M, et al. The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients--the EUGENE2 study. Diabetologia 2008; 51: 816-820.
80. Cauchi S, Nead KT, Choquet H, et al. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med Genet 2008; 9: 45.
81. Pascoe L, Tura A, Patel SK, et al. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 2007; 56: 3101-3104.
82. Staiger H, Machicao F, Stefan N, et al. Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS One 2007; 2: e832.
83. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007; 39: 770-775.
84. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445: 881-885.
85. Cauchi S, Del Guerra S, Choquet H, et al. Meta-analysis and functional effects of the SLC30A8 rs13266634 polymorphism on isolated human pancreatic islets. Mol Genet Metab 2010; 100: 77-82.
86. De Vos A, Heimberg H, Quartier E, et al. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 1995; 96: 2489-2495.
87. DiSilvestro RA. Zinc in relation to diabetes and oxidative disease. J Nutr 2000; 130: 1509S-1511S.
88. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
89. Giacconi R, Bonfigli AR, Testa R, et al. +647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol Genet Metab 2008; 94: 98-104.
90. Kanoni S, Nettleton JA, Hivert MF, et al. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes 2011; 60: 2407-2416.
91. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 2007; 104: 17040-17045.
92. Wenzlau JM, Liu Y, Yu L, et al. A common non-synonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 2008; 57: 2693-2697.
93. Okamoto T, Kuroki T, Adachi T, et al. Effect of zinc on early graft failure following intraportal islet transplantation in rat recipients. Ann Transplant 2011; 16: 114-120.